Press Briefing on the Regulatory Framework for Bioequivalence and it’s Relevance to the Nigerian Market
Bioequivalence (BE) is a critical scientific concept that ensures the quality, safety, and efficacy of generic drug products in comparison to their innovator counterparts. It establishes the interchangeability of generic medicines with their branded equivalents, relying on statistically significant clinical outcomes to confirm that generics deliver comparable therapeutic effects. Innovator drugs undergo rigorous phases of […]
